Get started
Author

Elizabeth R. Champney

Observed name: Elizabeth Champney
Observed institution: Adimab (United States)
ORCID: 0000-0002-6113-7970
Observed ORCID: 0000-0002-6113-7970
OpenAlex ID: A5008190875
Broad neutralization of SARS-related viruses by human monoclonal antibodies
2020 · Anna Z. Wec, Daniel Wrapp, et al. · Science · 529
PDF
Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability
2019 · Laila Shehata, Daniel P. Maurer, et al. · Cell Reports · 111
PDF
Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination
2022 · Chengzi I. Kaku, Elizabeth R. Champney, et al. · Science · 75
Evolution of antibody immunity following Omicron BA.1 breakthrough infection
2023 · Chengzi I. Kaku, Tyler N. Starr, et al. · Nature Communications · 70
PDF
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
2023 · Pete Schmidt, Kristin Narayan, et al. · Science Translational Medicine · 36
PDF
Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38
2024 · Olivia S. Shin, Stephanie R. Monticelli, et al. · Cell Reports · 21
Abstract A091: Rapid engineering of soluble T cell receptors for enhanced affinity via a high-throughput yeast-based platform
2025 · Saira Reyes, Vivien Qiao, et al. · Cancer Immunology Research
Works count: 7
Citation count: 842
H-index: 6
I10-index: 6
Year
Topic
Type